Soleno Therapeutics (SLNO) Other Operating Expenses (2014 - 2026)
Soleno Therapeutics (SLNO) reported Other Operating Expenses of $1.7 million for Q1 2026, down 43.31% year-over-year from $3.0 million in Q1 2025, and down 2.04% on a QoQ basis from $1.7 million in Q4 2025.
Soleno Therapeutics (SLNO) has 12 years of Other Operating Expenses data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Other Operating Expenses fell 43.31% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 19.68% YoY) and the FY2025 annual result came in at $8.2 million, up 154.04% from the prior year.
- Other Operating Expenses declined to $1.7 million in Q1 2026 per SLNO's latest filing, from $1.7 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $3.0 million in Q1 2025 and bottomed at -$858000.0 in Q1 2022.
- The 5-year median for Other Operating Expenses is $877000.0 (2024), against an average of $891882.4.
- The widest annual swing landed in 2022, when Other Operating Expenses sank 79.7%; it then surged 673.48% in 2023.
- Tracing SLNO's Other Operating Expenses over 5 years: stood at -$602000.0 in 2022, then soared by 279.57% to $1.1 million in 2023, then plunged by 69.75% to $327000.0 in 2024, then soared by 425.08% to $1.7 million in 2025, then slipped by 2.04% to $1.7 million in 2026.
- Per Business Quant, the three latest SLNO Other Operating Expenses figures stand at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 327,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 401,000.00 |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 313,000.00 |
| Mar 31, 2023 | 299,000.00 |
| Dec 31, 2022 | -602,000.00 |
| Sep 30, 2022 | 132,000.00 |
| Jun 30, 2022 | 616,000.00 |
| Mar 31, 2022 | -858,000.00 |
| Dec 31, 2021 | -3.33 Mn |
| Sep 30, 2021 | 551,000.00 |
| Jun 30, 2021 | 3.03 Mn |
| Mar 31, 2021 | -987,000.00 |
| Dec 31, 2020 | 140,000.00 |
| Sep 30, 2020 | 774,000.00 |
| Jun 30, 2020 | 2.84 Mn |
| Mar 31, 2020 | 584,000.00 |
| Dec 31, 2019 | -128,000.00 |
| Sep 30, 2019 | 28,000.00 |
| Jun 30, 2019 | 183,000.00 |
| Mar 31, 2019 | 206,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Sep 30, 2017 | 5,000.00 |
| Mar 31, 2017 | -2,000.00 |
| Dec 31, 2016 | 251.00 |
| Mar 31, 2016 | -94,000.00 |
| Dec 31, 2014 | 156,359.00 |
| Sep 30, 2014 | 84,000.00 |
| Jun 30, 2014 | 12,000.00 |